Patrick Soon-Shiong

CIK 1189020 · View on SEC EDGAR ↗

Activist

First SEC filing: Feb. 25, 2026 · Latest: Feb. 25, 2026

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 7 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

7 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
May 12, 2023 IBRX P None $30445859.00 — — Indirect — Acquired -100.0% (price as of 2026-08-20)
Aug. 31, 2022 IBRX P None $40407671.00 — — Indirect — Acquired -100.0% (price as of 2026-08-20)
Aug. 31, 2022 IBRX P None $55927342.00 — — Indirect — Acquired -100.0% (price as of 2026-08-20)
Aug. 31, 2022 IBRX P None $63375911.00 — — Indirect — Acquired -100.0% (price as of 2026-08-20)
Aug. 31, 2022 IBRX P None $55844638.00 — — Indirect — Acquired -100.0% (price as of 2026-08-20)
Aug. 31, 2022 IBRX P None $59524425.00 — — Indirect — Acquired -100.0% (price as of 2026-08-20)
Aug. 31, 2022 IBRX P None $40016261.00 — — Indirect — Acquired -100.0% (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Feb. 10, 2025 IBRX Restricted Stock Units Common Stock (822,368) — — 822,368 Acquired
Feb. 10, 2025 IBRX Stock Option (right to buy) Common Stock (2,812,500) $3.39 Feb. 10, 2035 2,812,500 Acquired
Feb. 22, 2024 IBRX Restricted Stock Units Common Stock (342,987) — — 342,987 Acquired
Feb. 22, 2024 IBRX Stock Option (right to buy) Common Stock (1,193,597) $5.24 Feb. 22, 2034 1,193,597 Acquired
May 12, 2023 IBRX Convertible Promissory Note Common Stock $2.28 Dec. 31, 2023 — Acquired
Aug. 31, 2022 IBRX Amended and Restated Convertible Promissory Note [F1] Common Stock $5.67 Sept. 30, 2025 — Acquired
Aug. 31, 2022 IBRX Amended and Restated Convertible Promissory Note [F1] Common Stock $5.67 Sept. 30, 2025 — Acquired
Aug. 31, 2022 IBRX Second Amended and Restated Convertible Promissory Note [F1] Common Stock $5.67 Sept. 30, 2025 — Acquired
Aug. 31, 2022 IBRX Second Amended and Restated Convertible Promissory Note [F1] Common Stock $5.67 Sept. 30, 2025 — Acquired
Aug. 31, 2022 IBRX Second Amended and Restated Convertible Promissory Note [F1] Common Stock $5.67 Sept. 30, 2025 — Acquired
Aug. 31, 2022 IBRX Second Amended and Restated Convertible Promissory Note [F1] Common Stock $5.67 Sept. 30, 2025 — Acquired
March 23, 2022 IBRX Stock Option (right to buy) Common Stock (350,000) $5.83 March 23, 2032 350,000 Acquired
March 23, 2022 IBRX Stock Option (right to buy) Common Stock (350,000) $5.83 March 23, 2032 350,000 Acquired
June 10, 2021 IBRX Stock Option (right to buy) Common Stock (26,064) $14.91 June 10, 2031 26,064 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

IBRX

Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2024 $625,777 — $1,797,252 $5,411,074 $372,600 — $13,991 $8,220,694
2023 $621,000 $232,875 — — — — $11,465 $865,340
2022 $616,962 — — $3,159,057 — — $12,232 $3,788,251

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.